The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose

Kristina M Utzschneider, Jenny Tong, Brenda Montgomery, Jayalakshmi Udayasankar, Fernando Gerchman, Santica M Marcovina, Catherine E Watson, Monica A Ligueros-Saylan, James E Foley, Jens J Holst, Carolyn F Deacon, Steven E Kahn

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

127 Citationer (Scopus)

Abstract

Udgivelsesdato: 2008-Jan
OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind31
Udgave nummer1
Sider (fra-til)108-113
Antal sider5
ISSN0149-5992
DOI
StatusUdgivet - 2007

Bibliografisk note

Keywords: Adamantane; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Nitriles; Placebos; Pyrrolidines; Single-Blind Method

Citationsformater